Orthopaedic Trainee Views on Robotic Technologies in Orthopaedics: A Survey-Based Study

  SFX Search  Buy Article Permissions and Reprints Abstract

The use of robotics is a growing area within the field of surgery, especially in orthopaedics. To date, there is no literature examining orthopaedic trainee perception of or comfort with robotics in orthopaedics. An assessment of the next generation's attitudes regarding this technology is necessary. An anonymous, national, web-based questionnaire containing 16 multiple-choice questions and 25 5-point Likert's scale questions was sent to 66 Accreditation Council for Graduate Medical Education (ACGME)-approved orthopaedic residency training programs. The survey was designed to discern the attitude of orthopaedic trainees toward robotics. Demographics, extent of exposure and training, and trainee perception regarding robotics were collected. A bivariate analysis using Pearson's Chi-square test or Fisher's was used to determine factors associated with trainee's future plans to use robotics. A total of 280 trainees completed the survey (response rate of 18%). Also, 67.9% have been exposed to and 42.9% trained to use robotics in surgical training. Of those trained, 44.4% were given increasing autonomy to use the technology. Further, 67.1% of trainees do not feel comfortable using robotic technology; however, 71.4% believe robotics has the potential to facilitate their education. Over 90% believe that robotic technology is here to stay. While residents have legitimate concerns about robotic implementation in orthopaedics, the majority of residents and fellows believe robotics will be a part of the future. However, few feel they receive adequate training or experience with the technology.

Keywords robotics - orthopaedics - residency training - technology - surgical training - survey Conflict of Interest

J.J.K. received others from Conformis (stock or stock options), Histogenics (stock or stock options), McKinsey and Co (paid consultant), Neogenomics (stock or stock options), Nuvasive (stock or stock options), Vericel (stock or stock options), and Wells Fargo (paid consultant). The rest authors declare no conflict of interest.

Publication History

Received: 18 October 2021

Accepted: 18 March 2022

Article published online:
18 July 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

留言 (0)

沒有登入
gif